Roswell Park Cancer Institute: Lung Neoplasms trials

The registry lists 42 Lung Neoplasms studies with Roswell Park Cancer Institute as lead sponsor. 9 are open to participants now and 9 have results posted.

Early Phase 1 2Phase 1 15Phase 2 17Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung CancerRecruitingNCT07718672Phase 2
• Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette SmokersNot yet recruitingNCT07553819Not applicable
• CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung CancerNot yet recruitingNCT07543172Phase 2
• GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung CancerRecruitingNCT07017829Phase 2
• New York Better Breathing StudyRecruitingNCT06869447Not applicable
• Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialRecruitingNCT06563388Phase 3
• Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for CancerRecruitingNCT05787834Not applicable
• Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung CancerRecruitingNCT05292521Not applicable
• Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung CancerRecruitingNCT04067830Phase 2
• Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung CancerCompletedNCT03735095Phase 1/2Results posted
• Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy RegimensCompletedNCT01948141Phase 2Results posted
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerCompletedNCT00843726Phase 2Results posted
• Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung CancerCompletedNCT00690924Not applicableResults posted
• Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
• Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air PassagesTerminatedNCT00528775Phase 2Results posted
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT00526890Phase 2Results posted
• Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00248495Phase 2Results posted
• Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung CancerWithdrawnNCT06943664Phase 2
• An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung CancerWithdrawnNCT06427369Phase 1
• Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer ScreeningCompletedNCT04635761Not applicable
• A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or RecurrenceCompletedNCT04298606Early Phase 1
• Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung CancerActive, not recruitingNCT04073745Phase 1
• CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerActive, not recruitingNCT02955290Phase 1/2
• Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT02947386Phase 1
• Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsWithdrawnNCT01971489Phase 1
• Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung CancerCompletedNCT01781741Early Phase 1
• Photodynamic Therapy in Treating Patients With Lung CancerCompletedNCT01668823Phase 1
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
• Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisCompletedNCT01014598Phase 1
• Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryCompletedNCT00732563Not applicable
• Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWithdrawnNCT00560495Phase 1
• Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung CancerCompletedNCT00526461Phase 1
• Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00182806Phase 2
• Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryCompletedNCT00057798Phase 2
• BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00054314Phase 2
• Surgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00054002Phase 2
• Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00025571Phase 1
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00023985Phase 1
• Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung CancerCompletedNCT00014066Phase 1
• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II MesotheliomaCompletedNCT00003974Phase 1
• Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and PaclitaxelCompletedNCT00003569